Last update 01 Nov 2024
Chengdu Tiantaishan Pharmaceutical Co., Ltd.

Chengdu Tiantaishan Pharmaceutical Co., Ltd.

Private Company|
2000|
Sichuan Sheng, China
|
1,000-5,000
|
www.cdttszy.com

Overview

Tags

Other Diseases
Nervous System Diseases
Endocrinology and Metabolic Disease
Synthetic peptide
Small molecule drug

Disease domain score
A glimpse into the focused therapeutic areas
Technology Platform
Most used technologies in drug development
Targets
Most frequently developed targets
Disease DomainCount
Endocrinology and Metabolic Disease1
Nervous System Diseases1
Top 5 Drug TypeCount
Synthetic peptide1
Small molecule drug1
Top 5 TargetCount
Opioid receptors x κ opioid receptor x μ opioid receptor1
AVPR(Vasopressin receptor)1

Related

2
Drugs associated with Chengdu Tiantaishan Pharmaceutical Co., Ltd.
Nalmefene Hydrochloride
Target
Opioid receptors x κ opioid receptor x μ opioid receptor
Mechanism
Opioid receptors antagonists [+2]
Active Org.
Tharimmune, Inc.Tharimmune, Inc. [+8]
Originator Org.
Baxter International, Inc.Baxter International, Inc.
Active Indication
Alcoholism [+3]
Inactive Indication
Gambling [+1]
Drug Highest PhaseApproved
First Approval Ctry. / Loc.
US
First Approval Date17 Apr 1995
Vasopressin
Target
AVPR
Mechanism
AVPR agonists
Active Org.
Daiichi Sankyo Co., Ltd.Daiichi Sankyo Co., Ltd. [+5]
Originator Org.
Daiichi Sankyo Co., Ltd.Daiichi Sankyo Co., Ltd.
Active Indication
Shock [+4]
Inactive Indication-
Drug Highest PhaseApproved
First Approval Ctry. / Loc.
JP
First Approval Date01 Nov 1959
1
Clinical Trials associated with Chengdu Tiantaishan Pharmaceutical Co., Ltd.
CTR20221292 / RecruitingPhase 3
加压素注射液治疗分布性休克低血压的有效性和安全性的多中心、随机、双盲、安慰剂对照的验证性临床试验
[Translation] A multicenter, randomized, double-blind, placebo-controlled confirmatory clinical trial on the efficacy and safety of vasopressin injection in the treatment of hypotension in distributive shock
100 Clinical Results associated with Chengdu Tiantaishan Pharmaceutical Co., Ltd.
Login to view more data
0 Patents (Medical) associated with Chengdu Tiantaishan Pharmaceutical Co., Ltd.
Login to view more data
100 Deals associated with Chengdu Tiantaishan Pharmaceutical Co., Ltd.
Login to view more data
100 Translational Medicine associated with Chengdu Tiantaishan Pharmaceutical Co., Ltd.
Login to view more data

Corporation Tree

Boost your research with our corporation tree data.
login
or
view full example data
Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 27 Nov 2024

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Phase 3 Clinical
1
1
Approved
Login to view more data

Current Projects

Drug(Targets)IndicationsGlobal Highest Phase
Nalmefene Hydrochloride
 ( Opioid receptors x κ opioid receptor x μ opioid receptor )		Opiate Overdose
More
Approved
Vasopressin
 ( AVPR )		-
Phase 3
Login to view more data

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Profit

Explore the financial positions of over 360K organizations with Synapse.
login
or
view full example data
Explore the financial positions of over 360K organizations with Synapse.

Grant & Funding(NIH)

Access more than 2 million grant and funding information to elevate your research journey.
login
or
view full example data
Access more than 2 million grant and funding information to elevate your research journey.

Investment

Gain insights on the latest company investments from start-ups to established corporations.
login
or
view full example data
Gain insights on the latest company investments from start-ups to established corporations.

Financing

Unearth financing trends to validate and advance investment opportunities.
login
or
view full example data
Unearth financing trends to validate and advance investment opportunities.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free